Analyst Consensus ?
ConsensusBuy13 ratings
Bullish1184.6%
Neutral17.7%
Bearish17.7%
FN2 Earnings Intelligence
TG Therapeutics, Inc. (TGTX) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 22, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Evercore ISI Group | Outperform | Outperform | Maintain | Nov 10, 2026 |
| HC Wainwright & Co. | Buy | Buy | Maintain | Sep 1, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Aug 7, 2026 |
| B. Riley Securities | Buy | Buy | Maintain | Jul 27, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Jul 7, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jan 15, 2026 |
| Ladenburg Thalmann | Buy | Buy | Maintain | May 2, 2024 |
| Jefferies | Buy | Buy | Maintain | Nov 1, 2023 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Feb 7, 2023 |
| HC Wainwright& Co. | Buy | Buy | Maintain | Aug 1, 2021 |
| B. Riley FBR | Buy | Buy | Maintain | Feb 9, 2021 |
| H.C. Wainwright | Buy | Buy | Maintain | Jan 17, 2020 |
| Raymond James | Outperform | Strong Buy | Downgrade | Sep 25, 2018 |
Upside is calculated against the persisted current price $63.34. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| H.C. Wainwright | Emily Bodnar | $78 | $46.17 | +23.1% | Aug 4, 2026 |
| Jefferies | Analyst unavailable | $83 | $54.4 | +31.0% | Jun 22, 2026 |
| H.C. Wainwright | Analyst unavailable | $70 | $39.75 | +10.5% | May 6, 2026 |
| Goldman Sachs | Analyst unavailable | $39 | $29.54 | -38.4% | Jan 15, 2026 |
| H.C. Wainwright | Emily Bodnar | $60 | $36.7 | -5.3% | Oct 6, 2025 |
| H.C. Wainwright | Edward White | $27.5 | $12.93 | -56.6% | Nov 5, 2024 |
| Goldman Sachs | Corinne Jenkins | $20 | $20.58 | -68.4% | Aug 6, 2024 |
| H.C. Wainwright | Edward White | $24.5 | $8.21 | -61.3% | May 3, 2024 |
| Cantor Fitzgerald | Analyst unavailable | $24 | $18.48 | -62.1% | Feb 7, 2023 |
| Evercore ISI | Analyst unavailable | $16 | $11.83 | -74.7% | Dec 30, 2022 |
| H.C. Wainwright | Edward White | $12 | $4.23 | -81.1% | Dec 29, 2022 |
| Goldman Sachs | Analyst unavailable | $5 | $7.26 | -92.1% | Apr 19, 2022 |
| Telsey Advisory | Mayank Mamtani | $11.5 | $3.46 | -81.8% | Apr 18, 2022 |
Track every rating change on TGTX the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.